Thomas Garvey

Thomas Garvey practices at Park Nicollet Child and Family Behavioral Health Center - HOPD in Saint Louis Park, Minnesota.

Thomas Garvey's NPI, 1689093247, was assigned on April 10, 2014. Thomas Garvey holds Minnesota license 63686.

Thomas Garvey's primary practice is Park Nicollet Child and Family Behavioral Health Center - HOPD, at 3800 Park Nicollet Blvd, Saint Louis Park, MN 55416.

Thomas Garvey's primary practice is Park Nicollet Child and Family Behavioral Health Center - HOPD in Saint Louis Park, Minnesota. Thomas Garvey is also affiliated with Froedtert Hospital. The medical group on file is Park Nicollet Clinic. Dmand AI also links Thomas Garvey to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account. Thomas Garvey's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Thomas Garvey practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Thomas Garvey's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Thomas Garvey's licenses on file in 2 states: Minnesota and Wisconsin.

CMS data shows 2,048 Medicare services from Thomas Garvey across 24 procedure codes in 2024, for 559 Medicare patients. Medicare paid $63,605 for them. Every service was in an office.

CMS counts 559 Medicare patients who saw Thomas Garvey in 2024. The largest group is 65 to 74, with 288 patients. 59% of them have high cholesterol, and 55% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Thomas Garvey's median patient age at 68, with 79% women.

In 2024, Thomas Garvey wrote 892 Medicare Part D claims for 169 patients. 80% of them were for generic drugs. CMS names the drug for 753 of them, across 14 drugs with 11 or more claims each, at $315,818 in total drug cost. In 2023, CMS named 513 claims across 10 drugs.

Thomas Garvey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Thomas Garvey as offering telehealth.

Dmand AI links 5 papers to Thomas Garvey, published from 2020 to 2023. The most frequent topics are Giant Cell Arteritis, Biopsy and Methotrexate. Thomas Garvey's most frequent co-authors are Kenneth J. Warrington, MD, Clement J. Michet, MD and Aaron J. Tande, MD.